PE115999A1 - Secretagogos de la hormona del crecimiento - Google Patents
Secretagogos de la hormona del crecimientoInfo
- Publication number
- PE115999A1 PE115999A1 PE1998000748A PE00074898A PE115999A1 PE 115999 A1 PE115999 A1 PE 115999A1 PE 1998000748 A PE1998000748 A PE 1998000748A PE 00074898 A PE00074898 A PE 00074898A PE 115999 A1 PE115999 A1 PE 115999A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- aryl
- growth hormone
- secretagogos
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/40—2,5-Pyrrolidine-diones
- C07D207/416—2,5-Pyrrolidine-diones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/42—Nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
- C07D231/40—Acylated on said nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/88—Nitrogen atoms, e.g. allantoin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Abstract
SE REFIERE A UN COMPUESTO DE FORMULA I, DONDE A ES ALQUILO C1-C6, ARILO, (ALQUIL C1-C6)ARILO, ENTRE OTROS; B ES NH2, NHR1, (ALQUIL C1-C6)NH2, ENTRE OTROS; R1 ES H, ALQUILO C1-C6, (ALQUIL C1-C6)OH o ALQUILIDENIL C1-C6)(OH)R2; R2 ES ALQUILO C1-C6, ALQUENILO C1-C6, (ALQUIL C1-C6)(O)(ALQUILO C1-C6), CO-O-ALQUILO C1-C6, ARILO o (ALQUIL C1-C6)ARILO; X ES UN ENLACE, ALQUILIDENILO C1-C6, O, S, NH o N(ALQUILO C1-C6); V ES UN GRUPO DE FORMULA (a, b, c, d); W ES S, O, NH, o CH2; "Y" Y Z SON N o CH; Y` ES N, S, CH2, O; Z' ES N, CH2; R4 Y R5 SON H, ALQUILO C1-C6, ARILO, (ALQUIL C1-C6)COR7, ENTRE OTROS; R7 ES H, ALQUILO C1-C6, PIRROLIDINILO, PIPERIDINILO, HOMOPROLINA O PROLINA; D ES C(O)R6, (ALQUIL C1-C6)OH, (ALQUIL C1-C6)C(O)R6, ENTRE OTROS; R6 ES H, ALQUILO C1-C6, ARILO, ENTRE OTROS; E ES H, ALQUILO C1-C6, C(O)ALQUILO C1-C6, ENTRE OTROS; G ES H, ALQUILO C1-C6, ARILO, (ALQUIL C1-C6)ARILO, ALQUENILO C1-C6; J ES H, ALQUILO, ARILO o (ALQUIL C1-C6)ARILO; L ES H, ALQUILO C1-C6, ARILO, ENTRE OTROS. TAMBIEN SE REFIERE A COMPUESTOS DE FORMULA IA, IB. EL COMPUESTO I ES UN SECRETAGOGO DE LA HORMONA DE CRECIMIENTO
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5614297P | 1997-08-19 | 1997-08-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE115999A1 true PE115999A1 (es) | 1999-11-26 |
Family
ID=22002443
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE1998000748A PE115999A1 (es) | 1997-08-19 | 1998-08-19 | Secretagogos de la hormona del crecimiento |
Country Status (24)
Country | Link |
---|---|
EP (1) | EP0933365A3 (es) |
JP (1) | JP2001515046A (es) |
KR (1) | KR20010027947A (es) |
CN (1) | CN1243567C (es) |
AR (1) | AR018010A1 (es) |
AU (1) | AU738204B2 (es) |
BR (1) | BR9811948A (es) |
CA (1) | CA2302467A1 (es) |
CO (1) | CO5121066A1 (es) |
EA (1) | EA002746B1 (es) |
HR (1) | HRP20000090A2 (es) |
HU (1) | HUP0002392A3 (es) |
ID (1) | ID25000A (es) |
IL (1) | IL134596A0 (es) |
MY (1) | MY138258A (es) |
NO (1) | NO20000823L (es) |
NZ (1) | NZ502947A (es) |
PE (1) | PE115999A1 (es) |
PL (1) | PL338883A1 (es) |
TR (1) | TR200000930T2 (es) |
TW (1) | TW577879B (es) |
UA (1) | UA58472C2 (es) |
WO (1) | WO1999008699A1 (es) |
ZA (1) | ZA987385B (es) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6639076B1 (en) | 1998-08-18 | 2003-10-28 | Eli Lilly And Company | Growth hormone secretagogues |
EP1112071A4 (en) * | 1998-08-18 | 2003-03-19 | Lilly Co Eli | SECRETAGOGUES OF GROWTH HORMONES |
US6828331B1 (en) | 1999-02-19 | 2004-12-07 | Eli Lilly And Company | Growth hormone secretagogues |
CO5160260A1 (es) * | 1999-02-19 | 2002-05-30 | Lilly Co Eli | Secretagogos de la hormona del crecimiento derivados de imi- dazol 1,4- substituido |
US6417397B1 (en) | 1999-10-04 | 2002-07-09 | The Regents Of The University Of California, San Diego | N-substituted alkylamino acids for use as amino-protecting groups |
EP1289526A4 (en) | 2000-05-30 | 2005-03-16 | Merck & Co Inc | MELANOCORTIN RECEPTOR AGONISTS |
US6756385B2 (en) * | 2000-07-31 | 2004-06-29 | Pfizer Inc. | Imidazole derivatives |
GT200100147A (es) * | 2000-07-31 | 2002-06-25 | Derivados de imidazol | |
US20040106665A1 (en) * | 2000-10-13 | 2004-06-03 | Kress Thomas Joseph | Resolution process for preparation of substantially pure (r) and (s) enantiomers of 2-(4-nitroimidazolyl)-4-methodxyphenylpropionic acid and salts thereof |
US7125840B2 (en) | 2001-10-09 | 2006-10-24 | Eli Lilly And Company | Substituted dipeptides as growth hormone secretagogues |
WO2003087069A2 (en) | 2002-04-09 | 2003-10-23 | Eli Lilly And Company | Dipeptidic growth hormone secretagogues |
CN100400519C (zh) * | 2002-12-18 | 2008-07-09 | 拜尔农科股份公司 | N-(取代的芳基甲基)-4-(二取代的甲基)哌啶和哌嗪 |
CN1934091B (zh) | 2004-03-23 | 2012-02-08 | 辉瑞产品公司 | 治疗神经变性障碍的咪唑化合物 |
BRPI0616141A2 (pt) | 2005-09-22 | 2011-06-07 | Pfizer Prod Inc | compostos imidazol para o tratamento de distúrbios neurológicos |
US7601844B2 (en) | 2006-01-27 | 2009-10-13 | Bristol-Myers Squibb Company | Piperidinyl derivatives as modulators of chemokine receptor activity |
US7615556B2 (en) | 2006-01-27 | 2009-11-10 | Bristol-Myers Squibb Company | Piperazinyl derivatives as modulators of chemokine receptor activity |
ES2604943T3 (es) | 2007-02-09 | 2017-03-10 | Ocera Therapeutics, Inc. | Moduladores macrocíclicos del receptor de la grelina y procedimientos de uso de los mismos |
TWI433838B (zh) | 2008-06-25 | 2014-04-11 | 必治妥美雅史谷比公司 | 作為趨化因子受體活性調節劑之六氫吡啶衍生物 |
US8642622B2 (en) | 2010-06-16 | 2014-02-04 | Bristol-Myers Squibb Company | Piperidinyl compound as a modulator of chemokine receptor activity |
UY34094A (es) | 2011-05-27 | 2013-01-03 | Novartis Ag | Derivados de la piperidina 3-espirocíclica como agonistas de receptores de la ghrelina |
MA20150428A1 (fr) | 2012-05-03 | 2015-11-30 | Novartis Ag | Sel de l-malate de dérivés de 2,7-diaza-spiro[4.5]déc-7-yle et ses formes cristallines à titre d'agonistes des récepteurs de ghreline |
SG11201600241RA (en) | 2013-07-18 | 2016-02-26 | Novartis Ag | Autotaxin inhibitors comprising a heteroaromatic ring-benzyl-amide-cycle core |
US9119832B2 (en) | 2014-02-05 | 2015-09-01 | The Regents Of The University Of California | Methods of treating mild brain injury |
JP6625541B2 (ja) * | 2014-08-29 | 2019-12-25 | 東京応化工業株式会社 | イミダゾール化合物、金属表面処理液、金属の表面処理方法、及び積層体の製造方法 |
WO2017075535A1 (en) | 2015-10-28 | 2017-05-04 | Oxeia Biopharmaceuticals, Inc. | Methods of treating neurodegenerative conditions |
CN107286041A (zh) * | 2016-04-01 | 2017-10-24 | 成都川科化工有限公司 | 一种n,n-二乙基甲酰胺的制备方法 |
CN108299218A (zh) * | 2017-01-12 | 2018-07-20 | 南京红杉生物科技有限公司 | 一种4-溴-d-苯丙氨酸的合成方法 |
CN110128285B (zh) * | 2019-06-24 | 2022-03-01 | 华北制药股份有限公司 | D-苯甘氨酸甲酯盐酸盐/d-二氢苯基甘氨酸甲酯盐酸盐的制备方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5206235A (en) * | 1991-03-20 | 1993-04-27 | Merck & Co., Inc. | Benzo-fused lactams that promote the release of growth hormone |
WO1994013696A1 (en) * | 1992-12-11 | 1994-06-23 | Merck & Co., Inc. | Spiro piperidines and homologs which promote release of growth hormone |
BR9407869A (pt) * | 1993-10-19 | 1996-10-29 | Merck & Co Inc | Combinaçao composiçao farmacêutica e processo para o tratamento de osteoporose |
US5492916A (en) * | 1993-12-23 | 1996-02-20 | Merck & Co., Inc. | Di- and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone |
US5798337A (en) * | 1994-11-16 | 1998-08-25 | Genentech, Inc. | Low molecular weight peptidomimetic growth hormone secretagogues |
WO1997007117A1 (en) * | 1995-08-21 | 1997-02-27 | Eli Lilly And Company | 2-acylaminopropanamines as growth hormone secretagogues |
EP0761220A1 (en) * | 1995-08-21 | 1997-03-12 | Eli Lilly And Company | 2-Acylaminopropanamides as growth hormone secretagogues |
-
1998
- 1998-08-17 ZA ZA9807385A patent/ZA987385B/xx unknown
- 1998-08-18 MY MYPI98003772A patent/MY138258A/en unknown
- 1998-08-18 TW TW087113593A patent/TW577879B/zh not_active IP Right Cessation
- 1998-08-18 AR ARP980104068A patent/AR018010A1/es unknown
- 1998-08-18 CO CO98047011A patent/CO5121066A1/es unknown
- 1998-08-18 EP EP98306622A patent/EP0933365A3/en not_active Withdrawn
- 1998-08-19 TR TR2000/00930T patent/TR200000930T2/xx unknown
- 1998-08-19 PE PE1998000748A patent/PE115999A1/es not_active Application Discontinuation
- 1998-08-19 CA CA002302467A patent/CA2302467A1/en not_active Abandoned
- 1998-08-19 IL IL13459698A patent/IL134596A0/xx unknown
- 1998-08-19 BR BR9811948-6A patent/BR9811948A/pt not_active IP Right Cessation
- 1998-08-19 NZ NZ502947A patent/NZ502947A/en unknown
- 1998-08-19 KR KR1020007001645A patent/KR20010027947A/ko not_active Application Discontinuation
- 1998-08-19 CN CNB988102390A patent/CN1243567C/zh not_active Expired - Fee Related
- 1998-08-19 JP JP2000509436A patent/JP2001515046A/ja active Pending
- 1998-08-19 EA EA200000239A patent/EA002746B1/ru not_active IP Right Cessation
- 1998-08-19 ID IDW20000306A patent/ID25000A/id unknown
- 1998-08-19 WO PCT/US1998/017229 patent/WO1999008699A1/en active Search and Examination
- 1998-08-19 AU AU90256/98A patent/AU738204B2/en not_active Ceased
- 1998-08-19 UA UA2000020987A patent/UA58472C2/uk unknown
- 1998-08-19 HU HU0002392A patent/HUP0002392A3/hu unknown
- 1998-08-19 PL PL98338883A patent/PL338883A1/xx unknown
-
2000
- 2000-02-17 HR HR20000090A patent/HRP20000090A2/hr not_active Application Discontinuation
- 2000-02-18 NO NO20000823A patent/NO20000823L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
HUP0002392A3 (en) | 2000-11-28 |
BR9811948A (pt) | 2000-08-22 |
WO1999008699A1 (en) | 1999-02-25 |
UA58472C2 (uk) | 2003-08-15 |
JP2001515046A (ja) | 2001-09-18 |
CA2302467A1 (en) | 1999-02-25 |
EP0933365A3 (en) | 2003-03-19 |
EA200000239A1 (ru) | 2000-10-30 |
TR200000930T2 (tr) | 2000-11-21 |
NO20000823D0 (no) | 2000-02-18 |
CN1243567C (zh) | 2006-03-01 |
AR018010A1 (es) | 2001-10-31 |
PL338883A1 (en) | 2000-11-20 |
ZA987385B (en) | 2000-04-18 |
KR20010027947A (ko) | 2001-04-06 |
CO5121066A1 (es) | 2002-01-30 |
MY138258A (en) | 2009-05-29 |
CN1276727A (zh) | 2000-12-13 |
IL134596A0 (en) | 2001-04-30 |
HRP20000090A2 (en) | 2001-04-30 |
NZ502947A (en) | 2001-11-30 |
TW577879B (en) | 2004-03-01 |
EP0933365A2 (en) | 1999-08-04 |
AU738204B2 (en) | 2001-09-13 |
AU9025698A (en) | 1999-03-08 |
ID25000A (id) | 2000-09-07 |
HUP0002392A2 (hu) | 2000-10-28 |
NO20000823L (no) | 2000-04-12 |
EA002746B1 (ru) | 2002-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE115999A1 (es) | Secretagogos de la hormona del crecimiento | |
ATE100453T1 (de) | Sulfhydryl enthaltende tricylische lactame und ihre pharmakologische verwendung. | |
EP0097534A3 (en) | Phosphonyl hydroxyacyl amino acid derivatives as antihypertensives | |
PE46899A1 (es) | Derivados de n-fenil-sulfonamida | |
AR247213A1 (es) | Preparacion de acido 7-¡(1-carboxi-3-fenilpropil)amino¿-3,4,6,7,8,12b-octahidro-6-oxopirido ¡2,1-a¿ o hexahidro-6-oxo-1h(1,4-tiazino¡3,4-a¿¡2¿-benzazepin-4-carboxilico, agentes hipertensivos. | |
DZ3482A1 (fr) | Secretagogues de l'hormone de croissance | |
DK0601799T3 (da) | Præparat med langvarig frigivelse | |
CO5200785A1 (es) | Uso terapeutico de quinazolina | |
ES8603711A1 (es) | Procedimiento para preparar compuestos benzimidazoles 2-piridilmetil-tio y sulfinil substituidos | |
ATE235472T1 (de) | N-(2-oxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepi - 3-yl)-3-amide | |
CA2379061A1 (en) | Antibacterial agents | |
PE20001241A1 (es) | Ciertas caprolactamas sustituidas, composiciones farmaceuticas que las contienen, y su uso en el tratamiento de tumores | |
BG99688A (en) | Insecticide derivatives of 5-substituted-2,4-diaminopyrimidines | |
HK1004554A1 (en) | Hemoregulatory peptides | |
IL75239A0 (en) | Beta-lactam antibiotics,their preparation,pharmaceutical compositions containing them and their use as growth-promoters in livestock rearing or as antioxidants | |
PE52496A1 (es) | Nueva sulfonamida y procedimiento de obtencion | |
SE8504346L (sv) | N-alkyl(en)-n-(o,o-disubstituerad tiofosforyl)-n',n'-disubstituerade glycinamider, sett att framstella dessa samt akaricid, insekticid och fungicid, innehallande dess foreningar som verksam bestandsdel | |
DE69004596D1 (de) | Benzodiazepin-Analoge. | |
DE3175327D1 (en) | Antihypertensive lactams | |
DK0856509T3 (da) | Fremgangsmåde til fremstilling af diacylimider | |
NO305989B1 (no) | Kondenserte heterocykliske glutaminsyrederivater | |
TR199901102T2 (xx) | Bisiklik amin t�revleri. | |
ATE96026T1 (de) | Verwendung heterozyklischer amide zur verhinderung der tumormetastasierung. | |
FI865229A0 (fi) | Pyranderivat. | |
ATE185561T1 (de) | Verbindungen der 1,4- bis(amino)benzo(g)phthalazenreihe |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration | ||
FD | Application declared void or lapsed |